NCT04913285 2025-12-24A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid TumorsPierre Fabre MedicamentPhase 1 Active not recruiting400 enrolled
NCT02605083 2020-11-02A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid TumorsEffector TherapeuticsPhase 1/2 Terminated66 enrolled
NCT03176485 2019-01-04Evaluation of Pathway Modulation by Raf, MEK, & Kinase InhibitorsUniversity of ArizonaPhase NA Completed45 enrolled